Datavault AI Inc. (DVLT) - Form 8-K Summary
Business Context and Reporting Period
Date of Report: February 25, 2025 (Signed February 28, 2025)
Company: Datavault AI Inc.
Event: Entry into a Material Definitive Agreement (Second Amendment to Asset Purchase Agreement with CompuSystems, Inc. "CSI").
This filing details amendments to the previously disclosed asset purchase agreement regarding the acquisition of CSI's assets, including customer contracts, trademarks, and intellectual property. The transaction requires stockholder approval.
Key Financial Metrics and Transaction Terms
The filing does not provide standard financial performance metrics (revenue, profit, cash flow) for the reporting period. Key financial terms of the amended transaction include:
- Closing Cash Consideration: Reduced to $5,000,000.
- Payment Instrument: $5,000,000 Initial Convertible Note issued at closing.
- Note Interest Rate: 10% per annum.
- Note Maturity: Second anniversary of the closing date.
- Conversion Terms: If not satisfied within 3 months post-closing, CSI may convert the note to common stock at $1.14 per share (in $500,000 increments).
- Early Repayment Trigger: Full repayment of principal and accrued interest required within 3 business days if the Company raises at least $15,000,000 in gross proceeds by March 31, 2025.
- Closing Costs Reimbursement: $500,000 payable to CSI at closing.
- Breakup Fee: To be released from escrow and paid to CSI within 3 business days of the amendment execution.
Material Changes Versus Prior Period
Compared to the original agreement and the first amendment (dated December 30, 2024), the following material changes were made:
- Consideration Reduction: The cash consideration was reduced to $5,000,000, now payable via a convertible note rather than immediate cash.
- Asset Scope Clarification: Assets and rights from the "EventsPass APA" are now explicitly defined as Transferred Assets/Liabilities. "A4Safe-Related Items" are clarified as Excluded Assets.
- Outside Date Extension: The deadline to consummate the transaction (Outside Date) was extended to April 30, 2025.
- Stockholder Notification: The Company agreed to file an information statement with the SEC within two business days after filing its Form 10-K to inform stockholders of the receipt of Stockholder Consent.
Guidance, Outlook, Risks, and Contingencies
Outlook and Conditions: The transaction is contingent upon stockholder approval. The Company intends to file a proxy statement for the 2025 Annual Meeting of Stockholders. The deal includes a "clawback" provision where the debt must be repaid immediately if the Company successfully raises $15 million in capital by March 31, 2025.
Risks and Contingencies:
- Transaction Failure: Risk that the deal may not close in a timely manner or at all, potentially affecting stock price.
- Capital Requirements: Risk that the Company may need to raise additional capital to execute its business plan, which may not be available on acceptable terms.
- Operational Integration: Risks related to retaining key employees, managing growth, and realizing anticipated benefits.
- Legal and Regulatory: Potential legal proceedings and the requirement for stockholder adoption of the agreement.
Investor Verification Checklist
- Verify the status of the $15,000,000 capital raise target required to trigger early repayment of the convertible note by March 31, 2025.
- Confirm the timeline for the filing of the Proxy Statement (Schedule 14A) and the date of the 2025 Annual Meeting of Stockholders.
- Review the full text of the Second Amendment (Exhibit 2.1) for specific definitions of "EventsPass APA" and "A4Safe-Related Items" to understand the exact scope of excluded assets.
- Monitor the Company's liquidity position given the immediate obligation to issue a $5,000,000 note and pay $500,000 in closing costs.
- Check for any subsequent filings regarding the release of the Breakup Fee from escrow.